• Optimized hiPSC Platelet Generation via Small Molecule Modul

  2026-06-26

  This study establishes a cost-effective, high-yield protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs), using an optimized differentiation scheme that leverages small molecule modulators and human platelet lysate. The approach reduces production time and cost, suggesting new scalable strategies for platelet manufacturing and cell therapy applications.

• Pazopanib Hydrochloride in Cancer Research: Applied Workflow

  2026-06-26

  Pazopanib Hydrochloride (GW786034) stands out as a multi-target anti-angiogenic agent that streamlines tumor inhibition studies across diverse cancer models. This guide bridges protocol rigor, troubleshooting, and advanced assay strategy—empowering oncology researchers to maximize translational impact using APExBIO’s trusted reagent.

• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im

  2026-06-25

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, more closely replicating the complexity of the tumor microenvironment. The findings show that stromal diversity significantly influences gene expression and drug response, advancing physiologically relevant preclinical testing and personalized therapy strategies.

• Network Pharmacology Reveals SFI Inhibits Glioma via SRC/PI3

  2026-06-25

  This study employs network pharmacology to clarify how Shenqi Fuzheng injection (SFI) inhibits glioma proliferation and migration by targeting the SRC/PI3K/AKT signaling pathway. By integrating in vitro, in vivo, and computational approaches, the research provides mechanistic insight and highlights specific molecular targets for anti-glioma therapy development.

• HyperScribe™ Poly (A) Tailing Kit: Precision in mRNA Stabili

  2026-06-24

  The HyperScribe™ Poly (A) Tailing Kit leverages E. coli Poly (A) Polymerase to deliver robust, scalable mRNA stability and translation efficiency improvements for demanding molecular biology workflows. Its streamlined protocol and troubleshooting flexibility empower researchers to confidently optimize mRNA for transfection and microinjection applications.

• Isoprinosine and Host Fusion Control: New Frontiers in Immun

  2026-06-23

  Explore how Isoprinosine (inosine pranobex) uniquely modulates immune responses and inhibits viral replication, with a special focus on the latest insights into host membrane fusion mechanisms. This article integrates mechanistic breakthroughs and practical assay guidance for researchers seeking advanced immunotherapy strategies.

• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im

  2026-06-23

  This study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal subpopulations, enabling nuanced study of tumor–stroma interactions and drug response. The approach markedly advances the physiological relevance of preclinical modeling and highlights key mechanisms underlying drug resistance in gastric cancer.

• Applied Use of FAK Inhibitor 14 in Cancer Biology Research

  2026-06-22

  FAK Inhibitor 14 empowers cancer researchers to dissect and block FAK-driven EMT and migration, especially in models with cholesterol-induced resistance. This article distills experimental protocols, troubleshooting, and lessons from recent mechanistic breakthroughs to help maximize reproducibility and interpretability in advanced tumor studies.

• Foretinib (GSK1363089): Precision Inhibition and Functional

  2026-06-22

  Explore Foretinib (GSK1363089) as a multikinase inhibitor for advanced cancer models. This article uniquely examines how functional metrics—beyond simple viability—redefine experimental rigor and translational relevance in preclinical oncology.

• DHHC9-STRN4 Palmitoylation Regulates YAP-Driven Cancer Metas

  2026-06-21

  The reference study uncovers how DHHC9-mediated palmitoylation of STRN4 activates YAP signaling, driving metastasis in adenocarcinomas. Pharmacological inhibition of DHHC9 effectively blocks this axis, offering a promising new therapeutic strategy for metastatic cancer.

• Tetrandrine Alkaloid: Mechanisms, Evidence, and Research Pro

  2026-06-20

  Tetrandrine is a well-characterized alkaloid used for ion channel modulation and neuroscience research. It acts predominantly as a calcium channel blocker, is DMSO-soluble, and is supplied in high-purity formats by APExBIO. This article details its mechanism, research benchmarks, and workflow integration.

• Applied Use of FAK Inhibitor 14 in Cancer Biology Research

  2026-06-19

  FAK Inhibitor 14 empowers researchers to dissect FAK-driven pathways in challenging cancer models, especially those with cholesterol-induced resistance. This guide details experimental workflows, troubleshooting strategies, and practical insights for achieving reliable inhibition of cell migration and EMT, drawing on recent mechanistic advances.

• Latrunculin B: Advanced Insights in Actin Disruption and Ass

  2026-06-19

  Explore in-depth how Latrunculin B serves as a precise actin cytoskeleton disruptor for advanced cellular research. This article uniquely analyzes real-world assay considerations and mechanistic nuances, providing expert guidance for leveraging this inhibitor in innovative experimental designs.

• RNA Clean and Concentrator Kit: Precision RNA Purification f

  2026-06-18

  Explore how the RNA Clean and Concentrator Kit enables uncompromised RNA purification from enzymatic reactions, supporting breakthroughs in mRNA therapeutics and inflammatory disease research. This in-depth analysis reveals the kit’s distinct advantages and practical applications, setting it apart from standard high-throughput RNA purification solutions.

• Crizotinib Hydrochloride: ALK Kinase Inhibitor in Assembloid

  2026-06-18

  Crizotinib hydrochloride is redefining experimental cancer biology by enabling precise, physiologically relevant inhibition of ALK, c-Met, and ROS1 in advanced assembloid models. This article details practical workflows, troubleshooting strategies, and protocol optimizations that harness its full power for translational research.

15398 records 1/1027 page Next 12345 下5页 Last page